HFSA announced yesterday that the 2021 Impact Factor (IF) for the society’s flagship publication, the Journal of Cardiac Failure (JCF) is 6.59, an increase from the 2020 IF of 5.712. JCF now ranks 38 out of 143 journals in the Cardiac & Cardiovascular Systems category, placing it in the upper third.
 
In late 2020, Robert J. Mentz, MD and Anuradha Lala, MD, were named the new JCF Editor-in-Chief and Deputy Editor. Their focus has been on high-quality science that improves the lives of patients living with heart failure and also developing and implementing robust diversity, equity, and inclusion policies across all aspects of the journal including among leadership, reviewers, authors, and content.  
 
With support from the heart failure community, JCF continues to implement new ways of bringing high-impact articles to the academic medical field. In addition to its expanded presence within the social media realm (Twitter, LinkedIn, YouTube), JCF brings different perspectives, provocative discussions and new ways to engage with all audiences interested in heart failure.
 
IF is calculated based on the number of citations in a given year of papers published during the preceding two-year period. The 2021 IF is the average number of citations in 2021 of all JCF papers published in 2019 and 2020, which was accepted by the previous editorial board led by Dr. Paul J. Hauptman. For more about how Impact Factor is calculated please visit Clarivate.com.
 
For more information, visit the Journal of Cardiac Failure website or contact HFSA Director, Journal Publishing, Meredith Hurt.